LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Leuko

Similar companies to Leuko

Leuko Tech Stack

Leuko uses 7 technology products and services including Google Analytics, Squarespace, Typekit, and more. Explore Leuko's tech stack below.

  • Google Analytics
    Analytics
  • Squarespace
    Content Management System
  • Typekit
    Font Scripts
  • Google Font API
    Font Scripts
  • Modernizr
    Javascript Libraries
  • Webpack
    Miscellaneous
  • Twitter
    Widgets

Media & News

Leuko's Email Address Formats

Leuko uses at least 1 format(s):
Leuko Email FormatsExamplePercentage
First@leuko.ioJohn@leuko.io
50%
First@leuko.ioJohn@leuko.io
50%

Frequently Asked Questions

Where is Leuko's headquarters located?

Minus sign iconPlus sign icon
Leuko's main headquarters is located at 8 St Marys St Boston, Massachusetts 02215 US. The company has employees across 2 continents, including North AmericaEurope.

What is Leuko's stock symbol?

Minus sign iconPlus sign icon
Leuko is a publicly traded company; the company's stock symbol is LKST.

What is Leuko's official website and social media links?

Minus sign iconPlus sign icon
Leuko's official website is leuko.io and has social profiles on LinkedIn.

How much revenue does Leuko generate?

Minus sign iconPlus sign icon
As of May 2024, Leuko's annual revenue reached $3.8M.

What is Leuko's NAICS code?

Minus sign iconPlus sign icon
Leuko's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Leuko have currently?

Minus sign iconPlus sign icon
As of May 2024, Leuko has approximately 15 employees across 2 continents, including North AmericaEurope. Key team members include Chief Data Scientist & Cofounder: A. B.Co-Founder And Ceo: C. C. G.Director Of Manufacturing: W. S.. Explore Leuko's employee directory with LeadIQ.

What industry does Leuko belong to?

Minus sign iconPlus sign icon
Leuko operates in the Medical Equipment Manufacturing industry.

What technology does Leuko use?

Minus sign iconPlus sign icon
Leuko's tech stack includes Google AnalyticsSquarespaceTypekitGoogle Font APIModernizrWebpackTwitter.

What is Leuko's email format?

Minus sign iconPlus sign icon
Leuko's email format typically follows the pattern of . Find more Leuko email formats with LeadIQ.

How much funding has Leuko raised to date?

Minus sign iconPlus sign icon
As of May 2024, Leuko has raised $5M in funding. The last funding round occurred on Sep 23, 2022 for $5M.

When was Leuko founded?

Minus sign iconPlus sign icon
Leuko was founded in 2017.
Leuko

Leuko

Medical Equipment ManufacturingMassachusetts, United States11-50 Employees

Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.

Section iconCompany Overview

Headquarters
8 St Marys St Boston, Massachusetts 02215 US
Website
leuko.io
Stock Symbol
LKST
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2017
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $5M

    Leuko has raised a total of $5M of funding over 8 rounds. Their latest funding round was raised on Sep 23, 2022 in the amount of $5M.

  • $10M

    Leuko's revenue is in the range of $10M

Section iconFunding & Financials

  • $5M

    Leuko has raised a total of $5M of funding over 8 rounds. Their latest funding round was raised on Sep 23, 2022 in the amount of $5M.

  • $10M

    Leuko's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.